Litcius/Paper detail

First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial

Ye Guo, Yi Luo, Qingyuan Zhang, Xiaoming Huang, Zhengdong Li, Liangfang Shen, Jifeng Feng, Yan Sun, Kunyu Yang, Minghua Ge, Xiaodong Zhu, Lin Wang, Yanyan Liu, Xiaohui He, Chunmei Bai, Kai Xue, Yan Zeng, Xinying Chang, Wenfeng Chen, Tongyu Lin

2021European Journal of Cancer61 citationsDOIOpen Access PDF

Topics & Concepts

CetuximabMedicineOncologyChemotherapyHead and neckInternal medicineHead and neck squamous-cell carcinomaBasal cellPhases of clinical researchHead and neck cancerRadiation therapySurgeryCancerColorectal cancerHead and Neck Cancer StudiesEsophageal Cancer Research and TreatmentColorectal and Anal Carcinomas
First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial | Litcius